A detailed history of Cadence Bank transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cadence Bank holds 52,260 shares of MRK stock, worth $5.2 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
52,260
Previous 52,442 0.35%
Holding current value
$5.2 Million
Previous $6.49 Million 8.6%
% of portfolio
0.41%
Previous 0.49%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $20,229 - $23,472
-182 Reduced 0.35%
52,260 $5.93 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $15,722 - $16,885
127 Added 0.24%
52,442 $6.49 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $41,106 - $47,897
363 Added 0.7%
52,315 $6.9 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $3,806 - $4,142
-38 Reduced 0.07%
51,952 $5.66 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $261,184 - $290,055
-2,537 Reduced 4.65%
51,990 $5.35 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $26,392 - $28,766
-243 Reduced 0.44%
54,527 $6.29 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $58,469 - $65,240
-568 Reduced 1.03%
54,770 $5.83 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $51,764 - $66,369
-592 Reduced 1.06%
55,338 $6.14 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $3.85 Million - $4.33 Million
45,556 Added 439.14%
55,930 $4.82 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $99,102 - $112,337
-1,187 Reduced 10.27%
10,374 $946,000
Q1 2022

May 13, 2022

SELL
$73.51 - $82.4 $22,053 - $24,720
-300 Reduced 2.53%
11,561 $948,000
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $10,119 - $12,675
-140 Reduced 1.17%
11,861 $909,000
Q3 2021

Nov 10, 2021

BUY
$71.68 - $78.83 $64,440 - $70,868
899 Added 8.1%
12,001 $901,000
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $4,570 - $5,055
-65 Reduced 0.58%
11,102 $864,000
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $3.35 Million - $3.95 Million
-48,652 Reduced 81.33%
11,167 $861,000
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $292,390 - $324,494
4,074 Added 7.31%
59,819 $4.89 Million
Q3 2020

Nov 09, 2020

BUY
$73.18 - $82.95 $12,294 - $13,935
168 Added 0.3%
55,745 $4.62 Million
Q2 2020

Jul 27, 2020

BUY
$70.42 - $80.13 $116,474 - $132,535
1,654 Added 3.07%
55,577 $4.3 Million
Q1 2020

Apr 30, 2020

BUY
$63.36 - $87.82 $63,993 - $88,698
1,010 Added 1.91%
53,923 $4.15 Million
Q4 2019

Feb 04, 2020

BUY
$77.58 - $87.54 $173,546 - $195,826
2,237 Added 4.41%
52,913 $4.81 Million
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $117,011 - $127,546
1,538 Added 3.13%
50,676 $4.27 Million
Q2 2019

Jul 30, 2019

BUY
$69.84 - $81.59 $196,110 - $229,104
2,808 Added 6.06%
49,138 $4.12 Million
Q1 2019

May 02, 2019

BUY
$69.58 - $79.36 $24,144 - $27,537
347 Added 0.75%
46,330 $3.85 Million
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $55,845 - $64,807
856 Added 1.9%
45,983 $3.51 Million
Q3 2018

Oct 25, 2018

BUY
$57.69 - $67.84 $21,229 - $24,965
368 Added 0.82%
45,127 $3.2 Million
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $92,459 - $108,630
-1,819 Reduced 3.91%
44,759 $2.72 Million
Q1 2018

May 03, 2018

BUY
$50.96 - $59.23 $309,683 - $359,940
6,077 Added 15.0%
46,578 $2.54 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $2.09 Million - $2.5 Million
40,501
40,501 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cadence Bank Portfolio

Follow Cadence Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadence Bank, based on Form 13F filings with the SEC.

News

Stay updated on Cadence Bank with notifications on news.